These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 16959686)

  • 1. Specific determination of plasmatic thrombin activity.
    Stief TW
    Clin Appl Thromb Hemost; 2006 Jul; 12(3):324-9. PubMed ID: 16959686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intrinsic coagulation activity assay.
    Stief TW; Otto S; Renz H
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):369-78. PubMed ID: 16788313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin generation by exposure of blood to endotoxin: a simple model to study disseminated intravascular coagulation.
    Stief TW
    Clin Appl Thromb Hemost; 2006 Apr; 12(2):137-61. PubMed ID: 16708116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The extrinsic coagulation activity assay.
    Stief TW; Wieczerzak A; Renz H
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):303-18. PubMed ID: 18586682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficiency of anti-activated factor X and anti-activated factor II anticoagulants.
    Stief TW
    Blood Coagul Fibrinolysis; 2007 Apr; 18(3):265-9. PubMed ID: 17413764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kallikrein activates prothrombin.
    Stief TW
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):97-8. PubMed ID: 18160576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the surface on thrombin generation.
    Stief TW
    Int J Lab Hematol; 2008 Aug; 30(4):269-77. PubMed ID: 18665823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of extrinsic hemostasis activation by low-molecular-weight heparin.
    Stief TW
    Blood Coagul Fibrinolysis; 2006 Nov; 17(8):633-7. PubMed ID: 17102649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of thrombin in plasma by heparin or arginine.
    Stief TW
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):146-53. PubMed ID: 17456623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine inhibits serpins.
    Stief TW
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):213-8. PubMed ID: 17456633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The recalcified coagulation activity.
    Stief TW
    Clin Appl Thromb Hemost; 2008 Oct; 14(4):447-53. PubMed ID: 18160574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of coagulation factors on extrinsic thrombin generation.
    Stief TW; Wieczerzak A; Renz H
    Blood Coagul Fibrinolysis; 2007 Mar; 18(2):105-12. PubMed ID: 17287625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fibrinogen functional turbidimetric assay.
    Stief TW
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):84-96. PubMed ID: 18160594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombin generation in plasma of healthy adults and children: chromogenic versus fluorogenic thrombogram analysis.
    Devreese K; Wijns W; Combes I; Van kerckhoven S; Hoylaerts MF
    Thromb Haemost; 2007 Sep; 98(3):600-13. PubMed ID: 17849049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of substrate and fibrin polymerization inhibitor on determination of plasma thrombin generation in vitro.
    Lau A; Berry LR; Mitchell LG; Chan AK
    Thromb Res; 2007; 119(6):667-77. PubMed ID: 16793122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel chromogenic peptide for prekallikrein/kallikrein determination.
    Huang WY; Wan X; Zhang S
    Clin Lab; 2009; 55(3-4):106-13. PubMed ID: 19462932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential.
    Hemker HC; Wielders S; Kessels H; Béguin S
    Thromb Haemost; 1993 Oct; 70(4):617-24. PubMed ID: 7509511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The fibrinogen antigenic turbidimetric assay (FIATA): the X2x test--the corrected chi-square comparison against the control-mean.
    Stief TW
    Clin Appl Thromb Hemost; 2007 Jan; 13(1):73-100. PubMed ID: 17164498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newer synthetic peptide substrates in coagulation testing: some practical considerations for automated methods.
    Svendsen LG; Fareed J; Walenga JM; Hoppensteadt D
    Semin Thromb Hemost; 1983 Oct; 9(4):250-62. PubMed ID: 6658459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inactivation of hemostatic factors by hematin.
    Green D; Reynolds N; Klein J; Kohl H; Ts'ao CH
    J Lab Clin Med; 1983 Sep; 102(3):361-9. PubMed ID: 6411843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.